— Updates, insights, and discussions on cancer-related topics

The FDA has broadened the approval for dostarlimab (Jemperli), now allowing its use alongside chemotherapy for treating patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient or microsatellite stable tumors.

A recent survey in the journal Menopause highlighted that 37% of women are unaware that postmenopausal bleeding is a critical indicator of endometrial cancer.

In another survey, only 38% of Americans reported having knowledge of available lung cancer screenings, according to the American Lung Association.

Research published in Lancet Public Health found that Generation X and millennials are facing higher rates of 17 cancer types when compared to previous generations.

A case-control study has suggested that cholesterol absorption inhibitors may help lower the risk of developing liver cancer, as reported in the journal Cancer.

Last winter, amidst the surge of COVID-19 cases, approximately 40% of National Cancer Institute-designated centers for cancer care implemented universal masking protocols in certain clinical areas. (JAMA Network Open)

Questions arise about the future of President Biden’s Cancer Moonshot initiative post-2024. (STAT)

Scientists have identified a potential source of breakthrough fungal infections among patients receiving allogeneic hematopoietic cell transplants. (Nature)

The presence of visceral pleural invasion in non-small cell lung cancer has been linked to worse disease-free and recurrence-free survival rates, according to a secondary analysis of a randomized clinical trial. (JAMA Oncology)

More than a decade after its original publication, a study from Digestive Diseases connecting inflammatory bowel disease with colorectal cancer has been retracted, following allegations of plagiarism. (Retraction Watch)

In a phase II trial, interleukin-12-based immunotherapy for advanced ovarian cancer improved overall survival when combined with standard chemotherapy, announced Imunon.

Interim findings from a phase III trial revealed that acalabrutinib (Calquence) and venetoclax (Venclexta), with or without obinutuzumab (Gazyva), led to enhanced progression-free survival in previously untreated chronic lymphocytic leukemia patients, compared with standard chemoimmunotherapy, according to AstraZeneca.

FibroGen announced it is halting the development of pamrevlumab, a connective tissue growth factor inhibitor, for metastatic pancreatic cancer, as two late-stage trials failed to demonstrate improvements in overall survival.

Long-time NPR correspondent Ina Jaffe has passed away at the age of 75 after battling breast cancer. (NPR)

Renowned "Top Chef" contestant Shirley Chung has revealed she has been diagnosed with stage IV tongue cancer. (CNN)